Share Icon Health Study Area: Cardiovascular Disease Chevron Icon Health Study Area: Genitourinary For Patients Health Study Area: Lung Cancer Page Icon Phone Icon For Caregivers Health Study Area: AutoImmune Disease Health Study Area: Melanoma Location Icon Print YouTube Icon For Parents Health Study Area: Lung Cancer Print Created with Sketch. Help Icon Green Check Icon Search Icon Instagram Created with sketchtool. Direction Arrow Icon Error Icon For Parents Health Study Area: Blood Cancer Help Icon Health Study Area: NASH Gender Both Bookmark Icon Health Study Area: Melanoma Created with Sketch. Glossary Print Health Study Area: Blood Cancer Health Study Area: Genitourinary Health Study Area: Gastrointestinal Cancer Mobile Menu Icon Created with Sketch. Health Study Area: Cardiovascular Disease Health Study Area: Women's Cancer Communities Map Icon Created with Sketch. For Caregivers Health Study Area: Fibrosis Health Study Area: AutoImmune Disease FAQs Health Study Area: Head and Neck Cancer Created with Sketch. For Clinicians Chevron Right Icon Gender Female Health Study Area: Breast Cancer Direction Arrow Icon Gender Both Right Arrow Icon LinkedIn Icon Green Check Icon Gender Male Health Study Area: Fibrosis For Patients Twitter Icon Email Icon Facebook Icon Health Study Area: Gastrointestinal Cancer Health Study Area: Head and Neck Cancer For Clinicians External Link Icon
Sök Study Connect
  • NCT01357668

Aktiv, rekryterar inte

An Observational Registry of Abatacept in Patients With Juvenile Idiopathic Arthritis - IM101-240

Uppdaterad: 17 februari, 2025   |   ClinicalTrials.gov


Utskriftsvänlig sammanfattning

ÄR DU INTRESSERAD AV DEN HÄR PRÖVNINGEN?
Skriv ut den här sidan och broschyren om kliniska prövningar som hjälp under samtalet med din läkare.
Använd broschyren ”Om att delta i en klinisk prövning” för att få vägledning om deltagandeprocessen i en klinisk prövning. Förstå de viktiga faktorerna som man måste tänka på före ett beslut och få hjälp med att formulera frågor till studiepersonalen.
Skriv ut den här sidan IM101-240
Ladda ned broschyren ”Om att delta i en klinisk prövning”

VÄLJ SPRÅK

Information om prövningen

  • Kön

  • 0-17

    Åldersintervall

  • Aktiv, rekryterar inte

Behandlingsalternativ

Studiegrupper
TILLDELAD BEHANDLING
Patients with JIA who are treated with Abatacept

Viktiga kriterier för deltagandet

For more information regarding BMS clinical trial participation, please visit www.BMSStudyConnect.com Inclusion Criteria: - Diagnosis of JIA (any subtype) - Age < 18 years at the time of enrollment unless currently or previously enrolled in an abatacept clinical trial and received abatacept - Receiving Abatacept at the time of enrollment as per treating physician's decision or received abatacept in a clinical trial - Parent or legally acceptable representative willing to participate in the study and sign the informed consent Exclusion Criteria: - Pregnant or nursing female at the time of enrollment - Prior malignancies if the patient has not been malignancy free for at least 5 years. - Any serious acute or chronic medical condition other than JIA, including chronic infection, which would compromise the patient's ability to participate in the study - Known poor compliance with clinic visits (based on physician judgment)

Vi rekommenderar att du kontaktar BMS för att rapportera biverkningar.
Biverkningar (oönskade händelser) och andra rapporterbara händelser definieras här
För att rapportera biverkningar (oönskade händelser) eller reklamera ett läkemedel: Medicinsk information

466-SE-2100058